Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug;83(8):1028-34.
doi: 10.1007/s00115-012-3565-y.

[HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis]

[Article in German]
A Liesz  1 , S Hähnel, K Korn, M Esiri, W Hacke, B Wildemann
Affiliations
Review

[HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis]

[Article in German]
A Liesz et al. Nervenarzt. 2012 Aug.

Abstract

Human T-cell lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological disease caused by infection with HTLV-1. The disorder is very rare in Europe but endemic in many parts of the world. The pathogenesis is not clearly characterized but is based on a possibly immune-mediated injury of the cervicothoracic spinal cord. Clinically, HAM/TSP constitutes a slowly progressive spastic paraparesis associated with bladder dysfunction and often mimics the course of autoimmune and neurodegenerative diseases. The diagnosis is based on typical symptoms as well as detection of HTLV-1 specific antibodies and proviral HTLV-1 DNA or HTLV-1 RNA. The therapy is limited to symptomatic treatment. Transmission of HTLV-1 can occur vertically by breast feeding, through sexual contact or via infected blood products. Based on a clinical case report, we present here a current review on the pathophysiology, epidemiology, clinical manifestations, diagnosis and treatment of HAM/TSP.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Clin Microbiol Rev. 2010 Jul;23(3):577-89 - PubMed
    1. Curr Opin Immunol. 2000 Aug;12(4):397-402 - PubMed
    1. J Infect Dis. 2002 Dec 1;186 Suppl 2:S187-92 - PubMed
    1. Nihon Hinyokika Gakkai Zasshi. 1994 Jul;85(7):1106-15 - PubMed
    1. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):68-77 - PubMed

MeSH terms

LinkOut - more resources